Department of Medical Microbiology and Medical Immunology, Rijnstate, President Kennedylaan 100, 6883 AZ, Velp, The Netherlands.
Diagn Microbiol Infect Dis. 2013 Dec;77(4):316-20. doi: 10.1016/j.diagmicrobio.2013.09.007. Epub 2013 Oct 14.
To prevent the spread of carbapenemase-producing bacteria, a fast and accurate detection of patients carrying these bacteria is extremely important. The Check-Direct CPE assay (Check-Points, Wageningen, The Netherlands) is a new multiplex real-time PCR assay, which has been developed to detect and differentiate between the most prevalent carbapenemase genes encountered in Enterobacteriaceae (blaKPC, blaOXA-48, blaVIM, and blaNDM) directly from rectal swabs. Evaluation of this assay using 83 non-duplicate isolates demonstrated 100% sensitivity and specificity and the correct identification of the carbapenemase gene(s) present in all carbapenemase-producing isolates. Moreover, the limit of detection (LoD) of the real-time PCR assay in spiked rectal swabs was determined and showed comparable LoDs with the ChromID CARBA agar. With an excellent performance on clinical isolates and spiked rectal swabs, this assay appeared to be an accurate and rapid method to detect blaKPC, blaOXA-48, blaVIM, and blaNDM genes directly from a rectal screening swab.
为了防止碳青霉烯酶产生菌的传播,快速准确地检测出携带这些细菌的患者极其重要。Check-Direct CPE 检测(Check-Points,瓦赫宁根,荷兰)是一种新的多重实时 PCR 检测方法,旨在直接从直肠拭子中检测和区分肠杆菌科中最常见的碳青霉烯酶基因(blaKPC、blaOXA-48、blaVIM 和 blaNDM)。使用 83 个非重复分离株评估该检测方法,结果显示 100%的敏感性和特异性,并正确识别所有产碳青霉烯酶分离株中存在的碳青霉烯酶基因。此外,还确定了实时 PCR 检测在加标直肠拭子中的检测限(LoD),并显示与 ChromID CARBA 琼脂的 LoD 相当。该检测方法在临床分离株和加标直肠拭子上具有出色的性能,似乎是一种直接从直肠筛查拭子中检测 blaKPC、blaOXA-48、blaVIM 和 blaNDM 基因的准确、快速方法。